doi: 10.3389/fendo.2022.934775 Received 03 May 2022 Accepted 28 June 2022 Published 26 July 2022 Volume 13 - 2022 Edited by Quan Zhang, University of Oxford, United Kingdom Reviewed by Beatriz Merino, University of Valladolid, Spain
Transient erythema, pruritus, or stinging may develop at the application site, typically resolving with continued use or brief treatment interruption
No proprietary access, product samples, paid sponsorship by Omzo, or undisclosed compensation influenced this article's content beyond the affiliate relationship disclosed in the opening block
Zepbound will be added to its formulary starting October 1
(See: Are compounded GLP-1 medications covered by insurance
When experiencing symptoms of dizziness or lightheadedness, patients should check their blood glucose to differentiate hypotension from hypoglycemia, as symptoms can overlap